Laura Oliphant Sells Shares of Aehr Test Systems
Director Laura Oliphant sold 57 shares of Aehr Test Systems on June 18, 2026.
Key Points
- Laura Oliphant, a director at Aehr Test Systems, sold 57 shares on June 18, 2026.
- Aehr Test Systems' stock traded at $112.81 on Monday, with a market cap of $3.63 billion.
- BlackRock, Inc. and Vanguard Capital Management LLC recently increased their stakes in Aehr Test Systems.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Director Laura Oliphant sold 57 shares of Aehr Test Systems, Inc. (NasdaqCM: AEHR) on June 18, 2026. This transaction was not part of a planned trading program. Shares of Aehr Test Systems traded at $112.81 on Monday.
What Changed in Laura Oliphant's Aehr Test Systems Position
Laura Oliphant, who serves as a director at Aehr Test Systems, reduced her holdings by selling 57 shares. This transaction was recorded on June 18, 2026, and was not pre-scheduled under a trading plan.
Other Institutional Activity in Aehr Test Systems
Among other institutional investors, BlackRock, Inc. grew its holdings by 159,794 shares, bringing its total to 2,286,899 shares valued at approximately $84.8 million, marking a 7.5% increase. FMR LLC reduced its position by 365,281 shares, leaving it with 2,142,639 shares worth about $79.4 million, a 14.6% decrease. AWM Investment Company, Inc. added 57,200 shares, now holding 1,593,971 shares valued at $59.1 million, reflecting a 3.7% increase. Price T Rowe Associates Inc /MD/ significantly increased its stake by 1,314,967 shares, reaching a total of 1,349,351 shares worth $50 million, a staggering 3824.4% increase. Vanguard Capital Management LLC opened a new position with 1,281,857 shares, valued at $47.5 million.
Aehr Test Systems, Inc. Stock Up 25.9%
On Monday, shares of Aehr Test Systems traded at $112.81. The company boasts a market capitalization of approximately $3.63 billion. It has a forward P/E ratio of 768.7, with a beta of 3.183, indicating high volatility. The stock's 52-week range is between $10.89 and $126.62, with a 50-day moving average of $94.47 and a 200-day moving average of $45.23. Aehr Test Systems maintains a strong financial position, with a current ratio of 10.97 and a quick ratio of 5.79, though it has a debt-to-equity ratio of 7.223.
$AEHR stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Aehr Test Systems reported revenue of $45.3 million, though it experienced a revenue decline of 43.7%. The company posted a net margin of -25.2% and a return on equity of -8.7%. Its next earnings report is expected on July 14, 2026.
Insider Buying and Selling at Aehr Test Systems, Inc.
In addition to Laura Oliphant's sale, several other insiders have sold shares recently. Executive VP of R&D Didier Wimmers sold 332 shares on June 3, 2026, at an average price of $114.59. CFO Chris Siu sold 350 shares at $93.62 on June 1, 2026, and another 2,070 shares at $107.06 on May 14, 2026. Howard Slayen sold 6,819 shares at $104.73 on May 13, 2026. Geoffrey Gates Scott sold 10,000 shares on April 29, 2026.
Analysts Set New Price Targets
Craig-Hallum maintained a hold rating with a $21.00 price target on January 9, 2026. Lake Street initiated coverage with a buy rating and a $29.00 target on December 17, 2025. The overall analyst consensus for Aehr Test Systems is a strong buy, with a mean target price of $63.67 based on three analyst opinions.
About Aehr Test Systems
Aehr Test Systems, Inc. is a technology company based in Fremont, California. It specializes in providing test solutions for semiconductor devices, including systems for testing, burn-in, and stabilization. The company's products are used in various applications, such as mobile phones, tablets, and computing devices. Aehr Test Systems operates in the United States, Asia, and Europe, employing approximately 136 people under the leadership of CEO Gayn Erickson.
Bottom Line
Laura Oliphant's recent sale of Aehr Test Systems shares is part of a broader pattern of insider activity at the company. Investors often keep an eye on such transactions for insights into company sentiment. Aehr Test Systems continues to navigate a challenging market with its high P/E ratio and volatile stock performance. As always, it's important to remember that insider sales can occur for many reasons unrelated to the company's prospects.
Get Aehr Test Systems, Inc. alerts
New 13F filings, insider trades, and analyst moves on $AEHR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.